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Volume 53, Number 17S Abstracts 59Swere more likely to be hypertensive (p0.002), present
with tissue loss (94.7% vs. 47.6%, p0.000), and have tibial
vessel disease (51.2% vs. 25.5%, p0.005). There were no
differences in primary procedures or peri-procedural
complications; however, diabetics with ESRD had antlmost 4-fold increase in length of stay (19.3 vs. 5.02
ays, p0.001; Fig 1). The groups had no differences in
atency rates, but diabetics with ESRD exhibited inferior
imb salvage (p0.006; Fig 2) and decreased overall
urvival (p0.022; Fig 3).
Conclusions:ESRD is associated withmore challenges
n diabetic patients treated for CLI. In our cohort, ESRD
id not affect long term patency rates after endovascular
rocedures, but substantially increased length of stay and
as associated with worse limb salvage and poorer long
erm survival.
uthor Disclosures: S. H. Ellozy: Nothing to disclose; P.
aries: Nothing to disclose; S. Kim: Nothing to disclose;
. L. Marin: Nothing to disclose; C. T. Spyris: Nothing
o disclose; R. O. Tadros: Nothing to disclose; V. J.
eodorescu: Nothing to disclose; W. Ting: Nothing to
isclose; A. Tye: Nothing to disclose; A. G. Vouyouka:
othing to disclose.
S114.
echnical Superiority and Clinical Excellence of Du-
lex Ultrasound Arterial Mapping vs Magnetic Reso-
ance Angiogram as the Sole Imaging Modality in
ypass Surgery and Endovascular Revascularization
or Critical Lower Ischemia Patients. Six Years Com-
arative Study in a Tertiary Referral Vascular Centre.
herif Sultan2, Wael Tawfick1. 1Vascular & Endovascular
urgery, Western Vascular Institute, Galway, Ireland; 2Gal-
ay Clinic, Galway, Ireland
Objectives: Endovascular revascularization (EvR) for
ritical lower ischemia (CLI) should be complemented
y non-invasive imaging for arterial mapping. Duplex
ltrasound arterial mapping (DUAM) can precisely dis-
riminate between echolucency due to thrombus vs ath-
rosclerotic occlusion. Our endeavour is to appraise
UAM as the exclusive imaging modality when planning
or CLI EvR.
Methods: Primary endpoint is sensitivity and specificity
f DUAM, compared to magnetic resonance angiogram
MRA) or DSA. Secondary endpoints were procedural,
emodynamic, clinical outcomes, cost-effectiveness, and
mputation-free survival.
DUAM was the sole pre-operative mapping modality.
RA was only used where DUAMwas inconclusive due to
eavy calcification.
From 2002 to 2009, 3490patients were referred with
eripheral vascular disease. 483patients underwent revascu-
arisation for TASC C/D lesions (EvR:n310; bypass
urgery[BS]:n173).
Results: DUAM displayed 97% sensitivity and 98%
pecificity in identifying lesions requiring intervention.
RA was utilized in 62 patients (12.8%) with 82% speci-
city. DUAM accurately identified the total number of
arget lesions for revascularisation (TLR) however MRA
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June Supplement 201160S Abstractsoverestimated it. The expenditure of DUAM is lower than
both DSA and MRA.
Of 421procedures based on DUAM, immediate clini-
cal improvement was comparable between EvR and BS,
with improvement to Rutherford category 3 or less 98% in
EvR and 97% in BS (P0.71). 6-year freedom from binary
re-stenosis was 72.8% EvR and 65.3% BS (P0.7001,
hr1.10, 95% CI  [0.69 to 1.74]). 6-year Amputation
Free Survival was 72.9% EvR and 71.2% BS (P0.9765,
hr0.95, 95% CI  [0.60 to 1.51]).
Comparing procedures performed based on DUAM to
those based on MRA, 6-year binary re-stenosis was 69% for
DUAM procedures Vs 57% for MRA procedures (P0.02,
hr0.255, 95% CI  [0.09-0.71]).
Conclusions: DUAM is an outstanding pre-operative
imaging tool and epitomizes a minimally invasive modality
to road-map EvR for CLI and offers precise consecutive
data with hemodynamic outcome and limb salvage superior
to EvR based onMRA.We believe that DUAM is econom-
ically proficient, primary modality for managing patients
with CLI.
Author Disclosures: S. Sultan: Nothing to disclose; W.
Tawfick: Nothing to disclose.
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Our Experience with Laser Angioplasty of 258 Lower
Extremities: Statin Use Improves Patency
Jung Kim, Sadaf S. Ahanchi, Jarrod Day, Brian Chen,
Babatunde Almaroof, Megan Caroll, Jean Panneton. East-
ern Virginia Medical School, Norfolk, VA
Objectives:The literature on atherectomy is difficult to
interpret due to a lack of uniform reporting standards. Our
objective was to review our experience with laser atherec-
tomy and assess factors affecting patency.
Methods: We conducted a retrospective chart review
of all laser atherectomies from January 1st, 2006 to May
31st, 2010. Periprocedural data was obtained from elec-
tronic medical records and subgroup analysis of isolated
superficial femoral artery (SFA) atherectomy was
completed.
Results: Laser atherectomy was performed on 258
limbs in patients with a mean age of 70. The procedural
indication was claudication (51%) or critical limb ischemia
(49%). Laser atherectomy was performed as a stand-
alone procedure in 6%, with percutaneous transluminal
angioplasty (PTA) in 73%, or with PTA/stenting in 22%.
Arterial location was iliac/common femoral (2%), SFA/
popliteal (66%), infrapopliteal (15%), or other (18%). Of
293 treated segments, 62.5% were occlusive and 37.5%
were stenotic.
Overall primary patency rates at 1 and 3 years were 48%
and 36%. Overall limb salvage rate for CLI limbs (130
limbs) was 93% at 1 year and 88% at 3 years. There was no
significant difference between the statin (120 patients) eersus non-statin group (114 patients) for any demo-
raphic variables. The 1 and 3 year primary patency rates
ere significantly different between statin (57%, 45%) ver-
us non-statin group (39%, 26%) (adjusted hazard ratio,
.54; p0.01).
Subgroup analysis of the isolated SFA interventions
howed a significant difference in primary patency in favor
f native versus in-stent arteries (p0.01).
Conclusions: Laser atherectomy was mostly used in
ombination with PTA with acceptable patency and satis-
actory limb salvage rate in CLI patients., The use of statins
ignificantly improves primary patency after laser
ngioplasty.
uthor Disclosures: S. S. Ahanchi: Nothing to disclose;
. Almaroof: Nothing to disclose; M. Caroll: Nothing to
isclose; B. Chen: Nothing to disclose; J. Day: Nothing to
isclose; J. Kim: Nothing to disclose; J. Panneton: Noth-
ng to disclose.
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ampbell, Mark C. Wyers, Elliot L. Chaikof, Frank B.
omposelli. Surgery, Beth Israel Deaconess Medical Cen-
er and Harvard Medical School, Boston, MA
Objectives: Prosthetic graft infection is a major and
eared complication of peripheral vascular surgery. We set
orth to investigate our institution’s experience with these
or arterial bypasses involving the femoral artery.
Methods: A retrospective cohort single institution re-
iew of prosthetic bypass grafts involving the femoral artery
rom 2005-2010 looked at patient demographics, BMI,
omorbidities, indications, location of bypass, type of pros-
hetic material, case urgency, previous ipsilateral bypasses
r percutaneous interventions, and evaluated mortality,
mputations, graft infections.
Results: There were 255 prosthetic grafts identified.
he graft infection rate was 4.7% with a median time to
resentation of 90 days after bypass. Multivariate analysis
hows redo (23% redo vs. 77% primary) bypass as a signifi-
ant predictor of graft infection (OR 4.1, 95% CI 1.3-12.9,
0.05). Redo bypasses made up 56% of graft infections.
emale gender and diabetes trended towards significance as
isk factors (OR 3.0, 95%CI .9-10.2, p.076,OR 3.6, 95%
I .96-13.7, p.058). Graft infection was predictive of
ajor lower extremity amputation (HR 11.3, 95% 3.2-
0.1, p .001). There was no difference in mortality.
nfected grafts were removed 77% of the time. Methicillin-
ensitive S. aureus (42%) and S. epidermidis (33%) were the
ost common pathogens isolated.
Conclusions: Redo bypasses are at a higher risk for
raft infection and that can lead to a higher rate of major
xtremity amputation. Alternate sources of vein and endo-
